Skip to content

Mescaline: all studies

Page 16 of 97: studies 151 to 160 of 965, newest first. Back to the mescaline overview

Research

Cactus Alkaloids. LI. Lack of Mescaline Translocation in Grafted Trichocereus

Journal of Natural Products March 1, 1982 Sunibhond Pummangura, Jerry L. Mclaughlin, R. C. Schifferdecker 10 citations

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTCactus Alkaloids. LI. Lack of Mescaline Translocation in Grafted TrichocereusS. Pummangura, J. L. McLaughlin, and R. C. SchifferdeckerCite this: J. Nat. Prod. 1982, 45, 2, 224–225Publication Date (Print):March 1, 1982Publication History Published online1 July 2004Published inissue 1 March...

Pharmacokinetic parameters of mescaline in rabbits

European Journal of Drug Metabolism and Pharmacokinetics 1982 C. Van Peteghem, A. Heyndrickx, W. Van Zele 3 citations

By means of a highly specific and sensitive mass fragmentographic method mescaline was measured in rabbit plasma samples, taken at various points after an i.v. injection. The pharmacokinetic behaviour conformed to the two-compartment open model. Half-life times of alpha and beta phases, velocity constants and steady-state distribution volumes of four subjects are reported.

DOI: 10.1007/bf03189535 (opens in new tab) Mescaline Pharmacokinetics Steady state chemistry Distribution mathematics +7

Sulfur analogues of psychotomimetic agents. Monothio analogs of mescaline and isomescaline

Journal of Medicinal Chemistry November 1, 1981 Peyton Jacob, Alexander T. Shulgin 20 citations

Two monothio analogues of mescaline and three monothio analogues of 2,3,4-trimethoxyphenethylamine (isomescaline) have been synthesized and characterized. Only the two mescaline analogues (3-and 4-thiomescaline) were found to be psychotomimetics in man, being 6 and 12 times more potent than mescaline, respectively. All five compounds can serve as substrates for bovine plasma monoamine oxidase...

DOI: 10.1021/jm00143a017 (opens in new tab) Mescaline Psychotomimetic Pharmacology Hallucinogen

LSD, mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility

European Journal of Pharmacology November 1, 1981 Heidrun Fink, Wolfgang Oelssner 44 citations

Microinjections of LSD (0.05 microgram), mescaline (0.5 microgram) and serotonin (10 microgram) into the medial raphe nucleus of rats resulted in a strong potentiation of apomorphine (1 mg/kg i.p.)-induced hypermotility. The potentiating effect of LSD or serotonin was suppressed by simultaneous injections of methysergide (0.05 microgram) or cyproheptadine (0.05 microgram) into the medial raphe...

Teratogenic effects of mescaline, epinephrine, and norepinephrine in the hamster

Teratology June 1, 1981 Kenneth S. Hirsch, Hans Fritz 19 citations

Abstract Mescaline was administered orally at doses of 16 and 32 mg/kg on the seventh through tenth days of gestation to pregnant cream‐strain hamsters. This treatment resulted in a dose‐dependent effect on reproductive success and skeletal ossification. The effect of mescaline on reproductive success included an increased number of resorptions resulting in a decreased litter size. The 32 mg/kg...

DOI: 10.1002/tera.1420230302 (opens in new tab) Mescaline Hamster Norepinephrine Pharmacology

Phencyclidine, Lysergic Acid Diethylamide, and Mescaline: Cerebral Artery Spasms and Hallucinogenic Activity

Science May 29, 1981 Bella T. Altura, Burton M. Altura 81 citations

Phencyclidine (PCP), lysergic acid diethylamide (LSD), and mescaline produced potent contractile responses on isolated basilar and middle cerebral arteries, where, in terms of potency, LSD > mescaline > PCP. All three drugs produced cerebrovasospasm in a concentration range which parallels that needed for their psychotomimetic and intoxicating actions. Specific receptors for PCP, which subserve...

Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat

Pharmacology, Biochemistry, and Behavior October 1, 1980 Randall L. Commissaris, K.E. Moore, Richard H. Rech 8 citations

Food-deprived male rats were trained to press a lever on a fixed ratio-40 (FR-40) operant schedule for food reinforcement. Administration of mescaline (4.0--10.0 mg/kg) immediately before the start of the operant session resulted in a cessation of responding for some portion of the 40-min period ("hallucinatory pause"). The duration of this pause was found to be dose-dependent. Although...

DOI: 10.1016/0091-3057(80)90289-0 (opens in new tab) Mescaline +-naloxone Pharmacology Antagonist +5

Severe aggression in rats induced by mescaline but not other hallucinogens

Psychopharmacology December 1, 1979 Robert J. Sbordone, Joseph A. Wingard, David A. Gorelick et al. 16 citations

Pairs of male Sprague-Dawley rats were administered mescaline, lysergic acid diethylamide (LSD), psilocin, N,N-dimethyltryptamine (DMT), 3,4-dimethoxyphenylethylamine (DMPEA), or 5-hydroxydopamine (5-OHDA) IP prior to being placed in a shock-elicited aggression situation. When foot shock was delivered, controls struck each other with their forepaws, but never engaged in either biting or...

Stimulation of human prolactin secretion by mescaline

Psychopharmacology September 1, 1979 Lothar Demisch, Manfred Neubauer 8 citations

Prolactin (PRL) and Growth Hormone (GH) secretions were studied in human serum after the oral administration of 5 mg/kg mescaline (3,4,5-trimethoxy-beta-phenylethylamine) or 2,3,4-trimethoxy-beta-phenylethylamine (2,3,4-TMPEA) respectively. Mescaline stimulated the secretion of PRL more than four-fold above base-line levels. Peak concentrations were found 90--120 min after drug intake. Five...

DOI: 10.1007/bf00427525 (opens in new tab) Mescaline Stimulation Prolactin Secretion +2